Trial intelligence / Profile preview

Oral nicotinamide for uremic pruritus

IRCT201202068940N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of nicotinamide in chronic kidney disease-associated pruritus (CKD-aP), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jun 2011; status: completed.

02

Drugs

nicotinamide
03

Conditions

chronic kidney disease-associated pruritus (CKD-aP)

Beyond the preview

Go deeper on IRCT201202068940N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201202068940N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call